<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02125812</url>
  </required_header>
  <id_info>
    <org_study_id>002</org_study_id>
    <nct_id>NCT02125812</nct_id>
  </id_info>
  <brief_title>Adjunctive Systemic Administration of Moxifloxacin in the Treatment of Aggressive Periodontitis</brief_title>
  <official_title>Adjunctive Systemic Administration of Moxifloxacin in the Treatment of Aggressive Periodontitis: Double-blind Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Facultad Nacional de Salud Publica</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universidad de Antioquia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Facultad Nacional de Salud Publica</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The adjunctive use of systemically administered antibiotics has been shown to provide a
      better clinical outcome, particularly in terms of probing depth (PD) reduction and
      attachment-level gain than SRP in subjects with Aggressive Periodontitis.

      The overall objective of this study is to evaluate the clinical and microbiological efficacy
      of moxifloxacin as an adjunct to scaling and root planing versus scaling and root planing
      over placebo in the treatment of aggressive periodontitis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>probing depth</measure>
    <time_frame>six months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical attachment level and probing depth</measure>
    <time_frame>6 moths</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Aggressive Periodontitis</condition>
  <arm_group>
    <arm_group_label>scaling and root planing</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>scaling and root planing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>scaling and systemic moxifloxacin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>scaling and root planing combined with systemic moxifloxacin</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>scaling and systemic moxifloxacin</intervention_name>
    <description>scaling and root planing (SRP) combined with systemic moxifloxacin</description>
    <arm_group_label>scaling and systemic moxifloxacin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>scaling and root planing</intervention_name>
    <description>scaling and root planing</description>
    <arm_group_label>scaling and root planing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  under 30 years old and systemically healthy, with at least 20 teeth present. Be
             willing to participate in the study which is corroborated by signing the informed
             consent form.

        Commit to attend post-therapeutic controls and stop drinking alcohol during the time of
        ingestion of antibiotics.

        Exclusion Criteria:

          -  Subjects in whom are contraindicated or with hypersensitivity to quinolones - Subjects
             who have undergone periodontal, surgical or mechanical antibiotic therapy six months
             before the start of the study according to interrogation.

        Women in pregnancy or lactation, corroborated with previous medical history and medical
        consultation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlos M Ardila, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad de Antioquia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Dentistry</name>
      <address>
        <city>Departamento de Antioquia</city>
        <state>Medellin</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <link>
    <url>http://odontologia.udea.edu.co</url>
    <description>Universidad de Antioquia</description>
  </link>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2014</study_first_submitted>
  <study_first_submitted_qc>April 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2014</study_first_posted>
  <last_update_submitted>May 29, 2014</last_update_submitted>
  <last_update_submitted_qc>May 29, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 2, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad de Antioquia</investigator_affiliation>
    <investigator_full_name>Carlos Martin Ardila Medina</investigator_full_name>
    <investigator_title>Titular Professor</investigator_title>
  </responsible_party>
  <keyword>Aggressive Periodontitis</keyword>
  <keyword>antimicrobial(s)</keyword>
  <keyword>microbiology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Aggression</mesh_term>
    <mesh_term>Aggressive Periodontitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Moxifloxacin</mesh_term>
    <mesh_term>Fluoroquinolones</mesh_term>
    <mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

